176 related articles for article (PubMed ID: 17339866)
1. Effects of supportive treatment such as antioxidant or leukotriene receptor antagonist drugs on inflammatory and respiratory parameters in asthma patients.
Tug T; Godekmerdan A; Sari N; Karatas F; Erdem ES
Clin Pharmacol Ther; 2007 Mar; 81(3):371-6. PubMed ID: 17339866
[TBL] [Abstract][Full Text] [Related]
2. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
[TBL] [Abstract][Full Text] [Related]
3. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
[TBL] [Abstract][Full Text] [Related]
4. [Urinary leukotrience E(4) level in children with asthma].
He MJ; Chen Q; Liu JM
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):909-12. PubMed ID: 20113659
[TBL] [Abstract][Full Text] [Related]
5. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
[TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma?
Pasaoglu G; Mungan D; Abadoglu O; Misirligil Z
J Asthma; 2008 Mar; 45(2):95-9. PubMed ID: 18350399
[TBL] [Abstract][Full Text] [Related]
8. Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction.
Rabinovitch N; Zhang L; Gelfand EW
J Allergy Clin Immunol; 2006 Sep; 118(3):635-40. PubMed ID: 16950282
[TBL] [Abstract][Full Text] [Related]
9. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
10. Urinary leukotriene E4 and 9 alpha, 11 beta-prostaglandin F concentrations in mild, moderate and severe asthma, and in healthy subjects.
Misso NL; Aggarwal S; Phelps S; Beard R; Thompson PJ
Clin Exp Allergy; 2004 Apr; 34(4):624-31. PubMed ID: 15080817
[TBL] [Abstract][Full Text] [Related]
11. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease.
Kirkil G; Hamdi Muz M; Seçkin D; Sahin K; Küçük O
Respir Med; 2008 Jun; 102(6):840-4. PubMed ID: 18295467
[TBL] [Abstract][Full Text] [Related]
13. Urine leukotriene E and eosinophil cationic protein in nasopharyngeal aspiration from young wheezy children.
Oh JW; Shin SA; Lee HB
Pediatr Allergy Immunol; 2005 Aug; 16(5):416-21. PubMed ID: 16101934
[TBL] [Abstract][Full Text] [Related]
14. Manifold significance of serum eosinophil cationic protein in asthmatic children.
Zubović I; Rozmanić V; Ahel V; Banac S
Acta Med Croatica; 2002; 56(2):53-6. PubMed ID: 12596625
[TBL] [Abstract][Full Text] [Related]
15. Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment.
Yalcin AD; Gorczynski RM; Parlak GE; Kargi A; Bisgin A; Sahin E; Kose S; Gumuslu S
Clin Lab; 2012; 58(1-2):89-96. PubMed ID: 22372350
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene E(4) in urine in patients with asthma and COPD--the effect of smoking habit.
Gaki E; Papatheodorou G; Ischaki E; Grammenou V; Papa I; Loukides S
Respir Med; 2007 Apr; 101(4):826-32. PubMed ID: 16965907
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.
Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA
J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
[TBL] [Abstract][Full Text] [Related]
19. Lack of systemic oxidative stress during PAF challenge in mild asthma.
Echazarreta AL; Rahman I; Peinado V; Barberà JA; Roca J; MacNee W; Rodríguez-Roisin R
Respir Med; 2005 May; 99(5):519-23. PubMed ID: 15823446
[TBL] [Abstract][Full Text] [Related]
20. Asthma outcome changes associated with use of the leukotriene-receptor antagonist zafirlukast.
Klingman D; Bielory L; Wang Y; Silverman S; Bell CF; Joy KA; Dever MT; Jones DA
Manag Care Interface; 2001 Feb; 14(2):62-6. PubMed ID: 11228819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
